The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 10, 2018

Filed:

Dec. 27, 2013
Applicants:

Drexel University, Philadelphia, PA (US);

Baruch S. Blumberg Institute, Doylestown, PA (US);

Arbutus Biopharma, Inc., Doylestown, PA (US);

Inventors:

Xiaodong Xu, Doylestown, PA (US);

Ju-Tao Guo, Lansdale, PA (US);

Tong Xiao, Edison, NJ (US);

Yanming Du, Cheshire, CT (US);

Timothy Block, Doylestown, PA (US);

Simon David Peter Baugh, Ringoes, NJ (US);

Hong Ye, Lansdale, PA (US);

Assignees:

Drexel University, Philadelphia, PA (US);

Baruch S. Blumberg Institute, Doylestown, PA (US);

Arbutus Biopharma, Inc., Warminster, PA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07C 311/16 (2006.01); C07D 213/75 (2006.01); C07D 213/76 (2006.01); C07D 309/04 (2006.01); C07D 215/38 (2006.01); C07D 215/42 (2006.01); C07D 217/24 (2006.01); C07D 319/18 (2006.01); C07D 231/40 (2006.01); C07D 231/42 (2006.01); C07D 239/26 (2006.01); C07D 261/14 (2006.01); C07D 263/48 (2006.01); C07D 263/50 (2006.01); C07D 203/26 (2006.01); C07D 263/58 (2006.01); C07D 205/04 (2006.01); C07D 277/46 (2006.01); C07D 277/52 (2006.01); C07D 211/96 (2006.01); C07D 295/26 (2006.01); C07D 295/30 (2006.01); C07D 213/40 (2006.01); C07D 305/08 (2006.01); C07C 309/89 (2006.01); C07C 311/17 (2006.01); C07C 311/18 (2006.01); C07C 311/19 (2006.01); C07C 311/20 (2006.01); C07C 311/48 (2006.01); C07C 233/66 (2006.01); C07C 317/14 (2006.01); C07D 295/32 (2006.01); C07D 319/16 (2006.01);
U.S. Cl.
CPC ...
C07C 311/16 (2013.01); C07C 233/66 (2013.01); C07C 309/89 (2013.01); C07C 311/17 (2013.01); C07C 311/18 (2013.01); C07C 311/19 (2013.01); C07C 311/20 (2013.01); C07C 311/48 (2013.01); C07C 317/14 (2013.01); C07D 203/26 (2013.01); C07D 205/04 (2013.01); C07D 211/96 (2013.01); C07D 213/40 (2013.01); C07D 213/75 (2013.01); C07D 213/76 (2013.01); C07D 215/38 (2013.01); C07D 215/42 (2013.01); C07D 217/24 (2013.01); C07D 231/40 (2013.01); C07D 231/42 (2013.01); C07D 239/26 (2013.01); C07D 261/14 (2013.01); C07D 263/48 (2013.01); C07D 263/50 (2013.01); C07D 263/58 (2013.01); C07D 277/46 (2013.01); C07D 277/52 (2013.01); C07D 295/26 (2013.01); C07D 295/30 (2013.01); C07D 295/32 (2013.01); C07D 305/08 (2013.01); C07D 309/04 (2013.01); C07D 319/16 (2013.01); C07D 319/18 (2013.01); C07B 2200/07 (2013.01); C07C 2101/02 (2013.01); C07C 2101/04 (2013.01); C07C 2101/08 (2013.01); C07C 2101/14 (2013.01);
Abstract

The present invention provides novel compounds of formula (I) and methods of use thereof. In certain embodiments, the compounds of the invention are useful as nucleocapsid assembly inhibitors. In other embodiments, the compounds of the invention are useful as pregenomic RNA encapsidation inhibitors of Hepatitis B virus (HBV). In yet other embodiments, the compounds of the invention are useful for the treatment of viral infection, including HBV and related viral infections.


Find Patent Forward Citations

Loading…